Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3S7D

Structural Basis of Substrate Methylation and Inhibition of SMYD2

Summary for 3S7D
Entry DOI10.2210/pdb3s7d/pdb
Related3S7B 3S7F 3S7J
DescriptorN-lysine methyltransferase SMYD2, Monomethylated p53 peptide, S-ADENOSYL-L-HOMOCYSTEINE, ... (6 entities in total)
Functional Keywordsmethyltransferase, p53, transferase
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm, cytosol (By similarity): Q9NRG4
Total number of polymer chains2
Total formula weight52074.72
Authors
Ferguson, A.D. (deposition date: 2011-05-26, release date: 2011-08-10, Last modification date: 2025-03-26)
Primary citationFerguson, A.D.,Larsen, N.A.,Howard, T.,Pollard, H.,Green, I.,Grande, C.,Cheung, T.,Garcia-Arenas, R.,Cowen, S.,Wu, J.,Godin, R.,Chen, H.,Keen, N.
Structural Basis of Substrate Methylation and Inhibition of SMYD2.
Structure, 19:1262-1273, 2011
Cited by
PubMed Abstract: Protein lysine methyltransferases are important regulators of epigenetic signaling. These enzymes catalyze the transfer of donor methyl groups from S-adenosylmethionine to specific acceptor lysines on histones, leading to changes in chromatin structure and transcriptional regulation. These enzymes also methylate nonhistone protein substrates, revealing an additional mechanism to regulate cellular physiology. The oncogenic protein SMYD2 represses the functional activities of the tumor suppressor proteins p53 and Rb, making it an attractive drug target. Here we report the discovery of AZ505, a potent and selective inhibitor of SMYD2 that was identified from a high throughput chemical screen. We also present the crystal structures of SMYD2 with p53 substrate and product peptides, and notably, in complex with AZ505. This substrate competitive inhibitor is bound in the peptide binding groove of SMYD2. These results have implications for the development of SMYD2 inhibitors, and indicate the potential for developing novel therapies targeting this target class.
PubMed: 21782458
DOI: 10.1016/j.str.2011.06.011
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon